Method of reducing toxicity of retinoids

Details for Australian Patent Application No. 2004205644 (hide)

Owner Wisconsin Alumni Research Foundation

Inventors Deluca, Hector F.; Highland, Margaret A.; Clagett-Dame, Margaret

Agent Pizzeys

Pub. Number AU-B-2004205644

PCT Pub. Number WO2004/065358

Priority 60/440,779 17.01.03 US

Filing date 16 January 2004

Wipo publication date 5 August 2004

Acceptance publication date 17 March 2011

International Classifications

C07J 9/00 (2006.01) Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

A61K 31/215 (2006.01)

C07C 403/20 (2006.01) Derivatives of cyclohexane or of a cyclohexene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene rings, e.g. vitamin A, beta-carotene, beta-ionone

Event Publications

4 August 2005 PCT application entered the National Phase

  PCT publication WO2004/065358 Priority application(s): WO2004/065358

17 March 2011 Application Accepted

  Published as AU-B-2004205644

14 July 2011 Standard Patent Sealed

9 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004205645-Magnetic separator

2004205643-Computational design of a water-soluble analog of a protein, such as phospholamban and potassium channel KcsA